Swedencare AB

As of June 30, 2026, Swedencare AB carries a market capitalization of 365.24M, placing it among publicly traded companies globally. Its enterprise value stands at 516.97M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Swedencare AB's next confirmed earnings release is scheduled for February 11, 2027.

As of June 30, 2026, Swedencare AB has 159.84M shares outstanding.

As of June 30, 2026, Swedencare AB trades at a trailing price-to-earnings ratio of 79.48. The price-to-sales ratio is 1.52, and the price-to-book ratio stands at 0.57.

As of June 30, 2026, Swedencare AB trades at an EV/EBITDA multiple of 12.57 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.15 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 38.23 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Swedencare AB trades at an EV/FCF ratio of 25.17, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 516.97M versus a market cap of 365.24M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Swedencare AB maintains a current ratio of 2.75, meaning it holds 2.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 24.88, indicating elevated leverage, while an interest coverage ratio of 4.96 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Swedencare AB posted a return on equity (ROE) of 0.71, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 1.20 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 0.52, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 1.31, useful for judging operating efficiency across full business cycles. The company generates approximately 397,377.56 in revenue per employee across its workforce of 604.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.15 indicates how many times Swedencare AB sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Swedencare AB recorded 1.74M in income tax expense. That works out to an effective tax rate of 27.49, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 6.34M, leaving 4.60M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Swedencare AB's stock has declined approximately 52.90% over the past 52 weeks. The 50-day moving average sits at 1.97, while the 200-day moving average is 2.30.

Over the twelve months ended June 30, 2026, Swedencare AB generated 240.21M in revenue and converted that into 4.60M in net income, yielding earnings per share of 0.03. EBITDA reached 41.11M, while operating income came in at 13.54M.

As of June 30, 2026, Swedencare AB holds 7.71M in cash and equivalents against 159.45M in total debt, resulting in a net debt position of 151.74M. Total book value stands at 640.84M, with working capital of 68.67M providing operational flexibility.

Swedencare AB produced 19.95M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -5.43M in capital expenditures, free cash flow totaled 14.53M - equivalent to 0.09 per share.

Over the twelve months ended June 30, 2026, Swedencare AB posted a gross margin of 58.35, reflecting its pricing power and cost economics. The operating margin of 5.64 and net profit margin of 1.91 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Swedencare AB paid dividends of 0.05 per share. The dividend payout ratio of 166.60 exceeds 100%, meaning the company is distributing more than it earns and funding the dividend from cash reserves, asset sales, or borrowing, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 3.98, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 4.76, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Swedencare AB shareholders.

Swedencare AB's most recent stock split took place on May 24, 2021 with a 1:5 split ratio.